Page 3 - Nasdaq Lbph News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq lbph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Lbph Today - Breaking & Trending Today

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Receives Average Recommendation of "Buy" from Analysts

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Free Report) has received an average rating of “Buy” from the six ratings firms that are currently covering the stock, Marketbeat Ratings reports. Six analysts have rated the stock with a buy rating. The average 12-month target price among analysts that have issued a report on the stock in […] ....

United States , Longboard Pharmaceuticals Inc , Citigroup Inc , Hedge Funds Weigh In On Longboard Pharmaceuticals , Metlife Investment Management , American International Group Inc , Longboard Pharmaceuticals Trading , Wells Fargo Company , Analyst Recommendations For Longboard Pharmaceuticals , Longboard Pharmaceuticals , News Ratings For Longboard Pharmaceuticals Daily , Cantor Fitzgerald , Get Free Report , Marketbeat Ratings , State Teachers Retirement System , International Group , Get Free , Longboard Pharmaceuticals Daily , Nasdaq Lbph ,

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Given Average Recommendation of "Buy" by Brokerages

Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Free Report) have been given a consensus recommendation of “Buy” by the six brokerages that are covering the stock, Marketbeat reports. Six research analysts have rated the stock with a buy recommendation. The average 12-month price target among brokers that have updated their coverage on the stock […] ....

United States , Analyst Recommendations For Longboard Pharmaceuticals , Asset Management Inc , Longboard Pharmaceuticals Stock Performance , Cantor Fitzgerald , News Ratings For Longboard Pharmaceuticals Daily , Longboard Pharmaceuticals Inc , Wells Fargo Company , Boothbay Fund Management , Goldman Sachs Group Inc , Longboard Pharmaceuticals , Get Free Report , State Teachers Retirement System , Sachs Group , Fund Management , Management Inc , Get Free , Longboard Pharmaceuticals Daily , Nasdaq Lbph ,

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Short Interest Update

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Free Report) saw a significant decline in short interest in the month of July. As of July 31st, there was short interest totalling 657,800 shares, a decline of 7.9% from the July 15th total of 714,400 shares. Based on an average daily volume of 124,100 shares, the short-interest ratio […] ....

United States , Longboard Pharmaceuticals Price Performance , Hedge Funds Weigh In On Longboard Pharmaceuticals , Wells Fargo Company , Metlife Investment Management , Cantor Fitzgerald , Goldman Sachs Group Inc , Longboard Pharmaceuticals Company Profile , Citigroup Inc , Longboard Pharmaceuticals Inc , Longboard Pharmaceuticals , American International Group Inc , News Ratings For Longboard Pharmaceuticals Daily , Get Free Report , International Group , Life Investment Management , Goldman Sachs Group , Longboard Pharmaceuticals Daily , Nasdaq Lbph ,

Cantor Fitzgerald Equities Analysts Lower Earnings Estimates for Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Free Report) – Research analysts at Cantor Fitzgerald lowered their FY2023 earnings per share estimates for shares of Longboard Pharmaceuticals in a research note issued to investors on Monday, August 7th. Cantor Fitzgerald analyst C. Duncan now anticipates that the company will earn ($2.33) per share for the year, down […] ....

Cantor Fitzgerald , Health Asset Management , News Ratings For Longboard Pharmaceuticals Daily , Blackrock Inc , Asset Management Inc , Bourgeon Capital Management , Longboard Pharmaceuticals , Longboard Pharmaceuticals Trading , Longboard Pharmaceuticals Inc , Free Report , Longboard Pharmaceutical , Get Free Report , Capital Management , Management Inc , Longboard Pharmaceuticals Daily , Nasdaq Lbph , Earnings Estimates ,

Longboard Pharmaceuticals' (LBPH) Buy Rating Reiterated at HC Wainwright

Longboard Pharmaceuticals (NASDAQ:LBPH – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a research report issued to clients and investors on Monday, Benzinga reports. They presently have a $25.00 price objective on the stock. HC Wainwright’s price objective would indicate a potential upside of 264.43% from the […] ....

News Ratings For Longboard Pharmaceuticals Daily , Longboard Pharmaceuticals Company Profile , Analyst Recommendations For Longboard Pharmaceuticals , Bourgeon Capital Management , Health Asset Management , Longboard Pharmaceuticals Inc , Longboard Pharmaceuticals Price Performance , Blackrock Inc , Cantor Fitzgerald , Longboard Pharmaceuticals , Hedge Funds Weigh In On Longboard Pharmaceuticals , Asset Management Inc , Get Free Report , Capital Management , Management Inc , Longboard Pharmaceuticals Daily , Nasdaq Lbph , Reiterated Rating , Hc Wainwright ,